Beacon Pointe Advisors LLC Sells 2,695 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Beacon Pointe Advisors LLC decreased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 33.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,318 shares of the medical equipment provider's stock after selling 2,695 shares during the period. Beacon Pointe Advisors LLC's holdings in Intuitive Surgical were worth $2,776,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of ISRG. Atala Financial Inc bought a new stake in Intuitive Surgical during the 4th quarter worth $25,000. Berbice Capital Management LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter worth about $26,000. BankPlus Trust Department acquired a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $28,000. Hurley Capital LLC bought a new position in Intuitive Surgical in the 4th quarter valued at approximately $28,000. Finally, Summit Securities Group LLC acquired a new stake in Intuitive Surgical during the 4th quarter worth approximately $30,000. Institutional investors own 83.64% of the company's stock.

Insider Transactions at Intuitive Surgical

In related news, CFO Jamie Samath sold 188 shares of the stock in a transaction on Friday, February 28th. The stock was sold at an average price of $566.94, for a total value of $106,584.72. Following the completion of the sale, the chief financial officer now directly owns 7,162 shares of the company's stock, valued at approximately $4,060,424.28. This represents a 2.56 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Myriam Curet sold 408 shares of the firm's stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the transaction, the executive vice president now owns 353 shares in the company, valued at approximately $208,181.75. This trade represents a 53.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 30,913 shares of company stock valued at $15,981,143 over the last ninety days. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Trading Up 0.2 %

NASDAQ ISRG opened at $515.80 on Thursday. The company has a fifty day simple moving average of $506.68 and a 200 day simple moving average of $533.01. Intuitive Surgical, Inc. has a 12-month low of $367.39 and a 12-month high of $616.00. The company has a market cap of $184.87 billion, a P/E ratio of 80.47, a PEG ratio of 5.85 and a beta of 1.55.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The company had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. During the same period in the previous year, the firm posted $1.50 earnings per share. Sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analyst Weigh In

ISRG has been the subject of several analyst reports. Truist Financial dropped their price target on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a research note on Wednesday, April 23rd. Barclays cut their target price on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. BTIG Research set a $560.00 price target on Intuitive Surgical and gave the company a "buy" rating in a research note on Monday, April 14th. Citigroup lifted their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the stock a "buy" rating in a research note on Friday, January 24th. Finally, Robert W. Baird decreased their target price on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Five research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company's stock. According to data from MarketBeat, Intuitive Surgical presently has an average rating of "Moderate Buy" and an average price target of $598.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.